FDA clarifies drug ad oversight

This is a news story, published by KFF Health News, that relates primarily to FDA news.

News about health policy

For more health policy news, you can click here:

more health policy news

KFF Health News news

For more news from KFF Health News, you can click here:

more news from KFF Health News

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about health policy, you might also like this article about

consumer prescription drug advertisements

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest prescription drug ads news, advertised prescription drug news, news about health policy, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

prescription drug advertisements

KFF Health News

•

Setting the Record Straight on the FDA's Authority Over Drug Ads - KFF Health News

Summary

Nutrition label

80% Informative

In 2023 , FDA issued a final rule establishing five standards to help ensure that the major statement in ads for human prescription drugs in TV/radio format is presented to consumers in a clear, conspicuous, and neutral manner.

Companies have until Nov. 20, 2024 , to bring ads into compliance.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech